Advertisement
Advertisement

AIM

AIM logo

AIM ImmunoTech Inc.

1.28
USD
Sponsored
-0.06
-4.38%
Jan 09, 15:56 UTC -5
Closed
exchange

After-Market

1.31

+0.03
+2.27%

AIM Earnings Reports

Positive Surprise Ratio

AIM beat 14 of 29 last estimates.

48%

Next Report

Date of Next Report
Mar 30, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.97
Implied change from Q3 25 (Revenue/ EPS)
-100.00%
/
-38.22%
Implied change from Q4 24 (Revenue/ EPS)
-100.00%
/
-90.30%

AIM ImmunoTech Inc. earnings per share and revenue

On Nov 17, 2025, AIM reported earnings of -1.57 USD per share (EPS) for Q3 25, missing the estimate of -0.98 USD, resulting in a -59.42% surprise. Revenue reached 26.00 thousand, compared to an expected --, with a 0.00% difference. The market reacted with a -7.64% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.97 USD, with revenue projected to reach -- USD, implying an decrease of -38.22% EPS, and decrease of -100.00% in Revenue from the last quarter.
FAQ
For Q3 2025, AIM ImmunoTech Inc. reported EPS of -$1.57, missing estimates by -59.42%, and revenue of $26.00K, 0% as expectations.
The stock price moved down -7.64%, changed from $1.44 before the earnings release to $1.33 the day after.
The next earning report is scheduled for Mar 30, 2026.
Based on 3 analysts, AIM ImmunoTech Inc. is expected to report EPS of -$0.97 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement